Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Amicus Briefs in AMP v. USPTO: Alynylam Pharmaceuticals, Inc.

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- In an amicus brief filed on October 28 in the Association of Molecular Pathology v. U.S. Patent and Trademark Office ("Myriad") case, Alnylam Pharmaceuticals, Inc. supports reversal of the District Court's decision and asks the Federal Circuit "to provide clear guidance on patent-eligibility to remove the unnecessary cloud cast by the decision below." Alnylam begins its brief by noting that the biopharmaceutical company's "sole concern as amicus is to support the traditional interpretation of 'composition of matter' under Section 101 as embracing all forms of compositions -- including compositions which are derived from natural products and...

Full post as published by Patent Docs on December 16, 2010 (boomark / email).